Inovio Pharmaceuticals INO
NASDAQ INO
$1.44 -0.03 (-2.37%)
As of: Nov 12, 2026 · 10:08 AM EST

Inovio Pharmaceuticals (INO) Return on Sales [ROS] (2009 - 2026)

Updated

Inovio Pharmaceuticals (INO) reported Return on Sales [ROS] of -132871.32% for Q4 2025, down 115460.54 percentage points from -17410.77% a year earlier and down 83668.43 percentage points from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

Dating back to Q2 2010, Inovio Pharmaceuticals' Return on Sales [ROS] record includes 63 quarters.

  • Return on Sales [ROS] has declined for three consecutive years, with a five-year change of -131197.07 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -51616.91% in FY2024 (-34316.64 pp), -17300.28% in FY2023 (-14692.92 pp), -2607.35% in FY2022 (+14364.98 pp) and -16972.34% in FY2021 (-15298.09 pp).
  • The Q4 2025 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q2 2010.
  • Year over year, Return on Sales [ROS] gained in three of the last eight quarters, with an average year-over-year change of -22813.84 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q3 2022 (a gain of 20162.55 percentage points); the low point was Q4 2025 (a drop of 115460.54 percentage points).
  • Per Business Quant data, the three quarters before Q4 2025 came in at -49202.88% (Q3 2025), -52568.64% (Q2 2025) and -38336.97% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Inovio Pharmaceuticals 143.02 Mn -38.21 Mn - -6,532.24%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -6,532.24%
Dec 31, 2025 -132,871.32%
Sep 30, 2025 -49,202.88%
Jun 30, 2025 -52,568.64%
Mar 31, 2025 -38,336.97%
Dec 31, 2024 -17,410.77%
Sep 30, 2024 -58,709.67%
Jun 30, 2024 -32,945.87%
Mar 31, 2024 -18,334.78%
Dec 31, 2023 -26,686.29%
Sep 30, 2023 -9,152.63%
Jun 30, 2023 -16,391.97%
Mar 31, 2023 -38,238.24%
Dec 31, 2022 -44,876.83%
Sep 30, 2022 -390.61%
Jun 30, 2022 -13,276.13%
Mar 31, 2022 -36,033.33%
Dec 31, 2021 -12,573.76%
Sep 30, 2021 -20,553.16%
Jun 30, 2021 -30,496.56%
API Access

Inovio Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INO&period=max&api_key=YOUR_API_KEY